$5.45
4.14% day before yesterday
Nasdaq, Jan 02, 10:00 pm CET
ISIN
US37148K1007
Symbol
GBIO

Generation Bio Co Stock price

$5.45
+0.34 6.56% 1M
+2.07 61.14% 6M
-0.24 4.14% YTD
-5.66 50.95% 1Y
-33.86 86.15% 3Y
-295.36 98.19% 5Y
-241.46 97.79% 10Y
-241.46 97.79% 20Y
Nasdaq, Closing price Fri, Jan 02 2026
-0.24 4.14%
ISIN
US37148K1007
Symbol
GBIO
Industry

Key metrics

Basic
Market capitalization
$36.7m
Enterprise Value
$-52.9m
Net debt
positive
Cash
$89.6m
Shares outstanding
6.7m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.4 | 3.3
EV/Sales
negative | negative
EV/FCF
0.5
P/B
0.7
Financial Health
Equity Ratio
37.3%
Return on Equity
-152.7%
ROCE
-89.3%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$15.3m | $11.2m
EBITDA
$-85.2m | $-85.7m
EBIT
$-90.0m | $-86.2m
Net Income
$-62.6m | $-89.3m
Free Cash Flow
$-114.7m
Growth (TTM | estimate)
Revenue
-17.8% | -43.6%
EBITDA
8.0% | -15.4%
EBIT
7.8% | -8.8%
Net Income
56.9% | 32.2%
Free Cash Flow
-10.0%
Margin (TTM | estimate)
Gross
-
EBITDA
-557.8% | -764.3%
EBIT
-589.6%
Net
-410.1% | -796.3%
Free Cash Flow
-751.4%
More
EPS
$-9.3
FCF per Share
$-17.0
Short interest
1.0%
Employees
115
Rev per Employee
$170.0k
Show more

Is Generation Bio Co a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,082 stocks worldwide.

Generation Bio Co Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Generation Bio Co forecast:

7x Buy
64%
4x Hold
36%

Analyst Opinions

11 Analysts have issued a Generation Bio Co forecast:

Buy
64%
Hold
36%

Financial data from Generation Bio Co

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
15 15
18% 18%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 37 37
12% 12%
244%
- Research and Development Expense 68 68
8% 8%
445%
-85 -85
8% 8%
-558%
- Depreciation and Amortization 4.85 4.85
5% 5%
32%
EBIT (Operating Income) EBIT -90 -90
8% 8%
-590%
Net Profit -63 -63
57% 57%
-410%

In millions USD.

Don't miss a Thing! We will send you all news about Generation Bio Co directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Generation Bio Co Stock News

Neutral
PRNewsWire
19 days ago
MILWAUKEE , Dec. 15, 2025 /PRNewswire/ -- The Ademi Firm is investigating Generation Bio (Nasdaq: GBIO) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with XOMA Royalty Corporation. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.
Neutral
Business Wire
19 days ago
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Generation Bio Co. (NASDAQ: GBIO) to XOMA Royalty Corporation for $4.2913 per share and one non-transferable contingent value right per share entitling holders to receive potential payments under certain conditions is fair to Generation Bio shareholders. Halper Sadeh encourages Generat...
Neutral
GlobeNewsWire
19 days ago
- Acquisition provides XOMA Royalty with potential milestone and royalty payments under Generation Bio's collaboration with Moderna -
More Generation Bio Co News

Company Profile

Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of eight programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was founded in 2016 and is headquartered in Cambridge, Massachusetts.

Head office United States
CEO Cameron McDonough
Employees 115
Founded 2016
Website generationbio.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today